SERVICES

“Buoyed by the robust growth of global biopharma, we set up our R&D service pipeline in the United States with the aim of developing our platform in two core markets. This way, Genetron can not only synchronize its services but also establish industry benchmarks, facilitating future Sino-U.S. dual market approvals.”

YUNFU HU

CHIEF MEDICAL OFFICER, GENETRON

In 2020, Dr. Yunfu Hu (former Deputy Director of the FDA Center for Medical Devices and Radiological Health (CDRH)/Office of In-Vitro Diagnostic and Radiological Health (OIR)) joined Genetron Health as its CMO. During his FDA tenure, Dr. Hu oversaw the approval process for a number of the world’s first companion diagnostic products.

SERVICE OVERVIEW

01

COMPANION DIAGNOSTICS

Genetron’s comprehensive platform features innovative patented technologies such as ”One-Step Method“ and a nationwide marketing network, enabling our veteran registry team to provide clients with integrated companion diagnostic product R&D and commercialization services.

MORE
Detection of early-stage hepatocellular carcinoma...
Detection of early-stage hepatocellular carcinoma...

02

BIOMARKER TESTING

Accounting for the full biopharma R&D pipeline, Genetron’s one-stop solution ranges from clinical trial design consultations to patient recruitment, and from biomarker testing services (CAP & CLIA dual-certified laboratory quality control) to subsequent data mining.

MORE

03

ONCO DATABASE

Genetron’s big data platform helps enable precision testing for early stage research and targeted screening solutions for the users of biopharma partners. Our team provides industry-leading expertise and support for new drug development and validation.

MORE

BIOPHARMA PARTNERS

CONTACT US

4000-996-336*3
BD-IC@genetronhealth.com